|

Transcranial Photobiomodulation in Anxiety Disorders

RECRUITINGN/ASponsored by Francisco Gonzalez-Lima, PhD
Actively Recruiting
PhaseN/A
SponsorFrancisco Gonzalez-Lima, PhD
Started2025-09-01
Est. completion2027-09
Eligibility
Age18 Years – 100 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07133893

Summary

The investigators have previously shown that safe, non-invasive methods of brain stimulation such as the administration of transcranial infrared light can result in improvements to cognition and emotion. The investigators hypothesize that transcranial photobiomodulation (tPBM) can be used in conjunction with attention bias assessment and modification to reduce anxiety symptoms in individuals with sub-clinical anxiety.

Eligibility

Age: 18 Years – 100 YearsHealthy volunteers accepted
Inclusion Criteria:

* 18 years of age and older
* State-Trait Anxiety Index (STAI) questionnaire score between 40-59 (indicates moderate sub-clinical anxiety)
* Patient Health Questionnaire (PHQ-9) score between 1-9 (indicates minimal to mild sub-clinical depression)

Exclusion Criteria:

* STAI score less than 40 or greater than 59
* PHQ-9 score greater than 9
* Medication instability (i.e., medication change within 6 weeks)
* Indicated suicidal ideation
* Currently receiving tPBM treatment
* Current pregnancy

Conditions2

AnxietySymptoms of Anxiety

Locations1 site

The University of Texas at Austin
Austin, Texas, 78712
Francisco Gonzalez-Lima, Ph.D.512-537-5257utbrainproject@gmail.com

Find trials near these locations

Anxiety trials in AustinAll trials in Texas

Browse More Trials

Anxiety trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.